Mark Verratti Myriad Genetics Inc (MYGN) insider trading activity

Mark Verratti is Chief Commercial Officer of MYRIAD GENETICS INC. Currently has a direct ownership of 382,911 shares of MYGN, which is worth approximately $2.84 Million. The most recent transaction as insider was on Aug 25, 2022, when has been sold 1,031 shares (Common Stock) at a price of $24.89 per share, resulting in proceeds of $25,662. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 383K

32.37% 3M change

28.19% 12M change

Total Value Held $2.84 Million

Mark Verratti Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 25 2022	SELL Payment of exercise price or tax liability	$25,662 $24.89 p/Share	1,031 Reduced 0.42%	242,176 Common Stock
Apr 14 2022	BUY Grant, award, or other acquisition	-	10,000 Added 3.95%	243,207 Common Stock
Mar 24 2022	SELL Payment of exercise price or tax liability	$67,503 $25.32 p/Share	2,666 Reduced 1.13%	233,207 Common Stock
Mar 22 2022	BUY Grant, award, or other acquisition	-	19,238 Added 7.54%	235,873 Common Stock
Feb 16 2022	BUY Grant, award, or other acquisition	-	22,616 Added 9.45%	216,635 Common Stock
Oct 09 2021	SELL Payment of exercise price or tax liability	$257,539 $30.88 p/Share	8,340 Reduced 4.12%	194,019 Common Stock
Sep 26 2021	SELL Payment of exercise price or tax liability	$117,051 $33.31 p/Share	3,514 Reduced 1.71%	202,359 Common Stock
Sep 25 2021	SELL Payment of exercise price or tax liability	$224,709 $33.31 p/Share	6,746 Reduced 3.17%	205,873 Common Stock
Sep 21 2021	BUY Grant, award, or other acquisition	-	56,571 Added 21.02%	212,619 Common Stock
Aug 25 2021	SELL Payment of exercise price or tax liability	$37,664 $34.81 p/Share	1,082 Reduced 0.69%	156,048 Common Stock
Mar 24 2021	BUY Grant, award, or other acquisition	-	15,441 Added 8.95%	157,130 Common Stock
Oct 08 2020	BUY Grant, award, or other acquisition	-	31,258 Added 18.07%	141,689 Common Stock
Sep 30 2020	SELL Sale (or disposition) back to the issuer	$9,454 $13.04 p/Share	725 Reduced 0.65%	110,431 Common Stock

Mark Verratti

Chief Commercial Officer

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Value

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to MYRIAD GENETICS INC

Track Activities on MYGN

Account